Advances in Brain Tumor Therapy
From Molecular Mechanisms to Clinical Practice
- 1st Edition - August 1, 2026
- Latest edition
- Editors: Arun Kumar Singh, Rajwinder Kaur, Thakur Gurjeet Singh, Ashutosh Pareek, Niraj Kumar Jha
- Language: English
Advances in Brain Tumor Therapy: From Molecular Mechanisms to Clinical Practice explores the evolving landscape of brain tumor treatment, addressing challenges posed by these… Read more
This book serves as an essential resource for healthcare professionals, clinical researchers, medical students, and scientists, bridging the gap between basic science and clinical practice. By providing insights into the latest advancements and emerging technologies, it equips readers with the knowledge necessary to navigate the complexities of brain tumor therapy and prepare for future innovations.
- Provides an extensive examination of brain tumors, covering epidemiology, classification, pathogenesis, and current treatment modalities
- Emphasizes innovative treatment techniques and future research opportunities, preparing readers for potential breakthroughs in brain tumor therapy and the challenges that lie ahead in the field
- Bridges the gap between fundamental research and clinical applications by detailing the latest advancements in therapeutic approaches, including targeted therapies, immunotherapies, and personalized medicine strategies
2. Molecular Pathogenesis of Brain Tumors
3. Pharmacokinetics and Pharmacodynamics in Brain Tumor Treatment
4. Conventional Chemotherapeutic Approaches for Brain Tumor Treatment
5. Targeted Molecular Therapies for Brain Tumor
6. Immunotherapy and Brain Tumors
7. Epigenetic Therapies for Brain Tumor
8. Nanotechnology and Drug Delivery Systems for Brain Tumor
9. Stem Cells in Brain Tumor Therapy
10. Harnessing Oxidative Stress: Novel Therapeutics in Pediatric Brain Cancer
11. Advanced Imaging Techniques in Brain Tumor Diagnosis and Surgery
12. Combination Therapies for Brain Therapy: Synergistic Approaches
13. Decoding MGMT: Biochemistry, Drug Resistance, and Diagnostic Innovations
14. Molecular Mechanisms of Drug Resistance in Brain Therapy
15. Personalized Medicine in Brain Tumors
16. Innovations and Obstacles in Pediatric Brain Cancer Therapy
17. Clinical Trials and Regulatory Aspects for Brain Tumor Treatment
18. Future Directions in Brain Tumor Therapy
19. Case Studies and Real-World Applications
- Edition: 1
- Latest edition
- Published: August 1, 2026
- Language: English
AS
Arun Kumar Singh
RK
Rajwinder Kaur
TS
Thakur Gurjeet Singh
Dr. Thakur Gurjeet Singh is a pharmacology researcher with extensive graduate training in clinical and preclinical drug development. His work focuses on the neuroprotective mechanisms of pharmacological preconditioning in neurodegenerative disorders such as Alzheimer’s disease, Parkinsonism, stroke, epilepsy, and dementia. He has investigated key protective pathways involving adenosine, opioids, CGRP, calcium signaling, protein kinase-C, heat shock proteins, and MAP kinase. His research also explores novel therapeutic pathways using agents such as morphine and capsaicin, with additional expertise in mechanistic studies of substance dependence, including nicotine, alcohol, and morphine addiction. Dr. Singh’s core competencies include animal model development and validation, anesthetic and preconditioning techniques, histopathological analysis, and behavioral data evaluation. His broader interests include ALS, stem cell therapy, and movement disorders such as tardive dyskinesia.
AP
Ashutosh Pareek
Dr. Ashutosh Pareek, Professor at Banasthali Vidyapith with over 15 years of experience in pharmaceutical sciences, holds gold medals for his Master's and Bachelor's degrees in Pharmacy. Dr. Pareek specializes in neuropharmacology and innovative drug delivery systems, focusing on neurodegenerative disorders, cancer, and autoimmune diseases. His research includes developing advanced drug delivery systems for immunomodulators like naringenin. Dr. Pareek leads a research team working on these critical health issues and has published over 45 research papers and authored five technical books. He holds an international formulation patent and has received numerous awards, including the Zee National Achievers Award 2023. His work is funded by national and international agencies such as ICMR, DST-SERB, DBT, the American Association of Pharmaceutical Scientists, and the International Brain Research Organization. He serves as a Review Editor for Frontiers in Pharmacology and Frontiers in Oncology and reviews for leading journals by Elsevier, Springer, and Bentham.
NJ
Niraj Kumar Jha
Dr. Niraj Kumar Jha is an assistant professor in the Department of Biotechnology at Sharda University, Greater Noida, India, and a member of the Royal Society of Biology, London. Previously, he served as an assistant professor at the Noida Institute of Engineering and Technology, affiliated with Abdul Kalam Technical University. He holds an MSc in Biotechnology from Vellore Institute of Technology and a Ph.D. in Biotechnology from Delhi Technological University, supported by a research fellowship from the Department of Biotechnology, Government of India. A prolific author, Dr. Jha has published over 150 scholarly works and presented his research at international conferences. He currently serves as an associate editor for IET Nanobiotechnology and guest editor for several high-impact journals. His research interests focus on the pathogenesis of neurodegenerative, cancer, respiratory, and cardiovascular diseases, as well as the therapeutic roles of small molecules from natural or synthetic sources.